MYELOSUPPRESSION ADULT

Clinical trials for MYELOSUPPRESSION ADULT explained in plain language.

Never miss a new study

Get alerted when new MYELOSUPPRESSION ADULT trials appear

Sign up with your email to follow new studies for MYELOSUPPRESSION ADULT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

Drug trial aims to shield patients from harsh chemo side effects while fighting bladder cancer

Disease control Terminated

This study tested if adding a drug called trilaciclib to standard first-line chemotherapy and immunotherapy could better control advanced bladder cancer. The goal was to see if trilaciclib could help patients live longer without their cancer worsening while also protecting their …

Matched conditions: MYELOSUPPRESSION ADULT

Phase: PHASE2 • Sponsor: G1 Therapeutics, Inc. • Aim: Disease control

Last updated Mar 30, 2026 14:34 UTC

MYELOSUPPRESSION ADULT

Get alerted when new MYELOSUPPRESSION ADULT trials appear

Drug trial aims to shield patients from harsh chemo side effects while fighting bladder cancer